Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -156,000 | 178,000 | 292,000 | 193,000 | 149,000 |
| Depreciation Amortization | 26,000 | 28,000 | 40,000 | 13,000 | 14,000 |
| Accounts receivable | 15,000 | 79,000 | -33,000 | -59,000 | -27,000 |
| Accounts payable and accrued liabilities | -103,000 | -101,000 | 58,000 | 5,000 | 142,000 |
| Other Working Capital | -19,000 | -79,000 | 29,000 | 141,000 | 338,000 |
| Other Operating Activity | 44,000 | 46,000 | -83,000 | 2,000 | -209,000 |
| Operating Cash Flow | $-193,000 | $151,000 | $303,000 | $295,000 | $407,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,000 | -7,000 | -11,000 | -30,000 | -20,000 |
| Purchase Sale Intangibles | N/A | 4,000 | 7,000 | -13,000 | -15,000 |
| Other Investing Activity | 0 | 5,000 | 7,000 | -13,000 | -15,000 |
| Investing Cash Flow | $-4,000 | $-2,000 | $-4,000 | $-43,000 | $-35,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 487,000 | N/A |
| Debt Repayment | -4,000 | -4,000 | -240,000 | -573,000 | -78,000 |
| Common Stock Issued | 1,000 | N/A | 3,000 | 2,000 | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -69,000 |
| Other Financing Activity | -7,000 | -9,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-10,000 | $-13,000 | $-237,000 | $-84,000 | $-147,000 |
| Exchange Rate Effect | 5,000 | N/A | -1,000 | 3,000 | N/A |
| Beginning Cash Position | 1,060,000 | 924,000 | 863,000 | 692,000 | 467,000 |
| End Cash Position | 858,000 | 1,060,000 | 924,000 | 863,000 | 692,000 |
| Net Cash Flow | $-202,000 | $136,000 | $61,000 | $171,000 | $225,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -193,000 | 151,000 | 303,000 | 295,000 | 407,000 |
| Capital Expenditure | -4,000 | -7,000 | -11,000 | -30,000 | -20,000 |
| Free Cash Flow | -197,000 | 144,000 | 292,000 | 265,000 | 387,000 |